Auskünfte zu Evalueserve Holdings AG
Bonitätsauskunft
Einschätzung der Bonität mit einer Ampel als Risikoindikator und weiteren hilfreichen Firmeninformationen.Mehr erfahren
Firmendossier als PDF
Kontaktinformationen, Veränderungen, Umsatz- und Mitarbeiterzahlen, Management, Besitzverhältnisse, Beteiligungsstruktur und weitere Firmendaten.Jetzt kostenlos abrufen
Über Evalueserve Holdings AG
- Evalueserve Holdings AG aus Zug ist im Bereich «Betreiben von übrigen Finanzinstitutionen» tätig und aktiv.
- Evalueserve Holdings AG hat 4 Personen im Management.
- Der Handelsregistereintrag der Firma wurde zuletzt am 06.01.2026 angepasst. Unter Meldungen sind alle bisherigen Handelsregistereinträge abrufbar.
- Die Firma Evalueserve Holdings AG ist unter der UID CHE-229.673.474 eingetragen.
- Unternehmen mit derselben Adresse wie Evalueserve Holdings AG: AA TopCo AG, Abacus Medicine Switzerland GmbH, Adamant BioNRG AG.
Management (4)
neueste Verwaltungsräte
Armin Kurt Meier,
Timo Juhani Vättö,
Dr. Christian Paul Casal,
Marc Ulrich Vollenweider
neuste Zeichnungsberechtigte
Armin Kurt Meier,
Timo Juhani Vättö,
Dr. Christian Paul Casal,
Marc Ulrich Vollenweider
Handelsregisterinformationen
Eintrag ins Handelsregister
18.12.2019
Rechtsform
Aktiengesellschaft
Rechtssitz der Firma
Zug
Handelsregisteramt
ZG
Handelsregister-Nummer
CH-170.3.044.085-5
UID/MWST
CHE-229.673.474
Branche
Betreiben von übrigen Finanzinstitutionen
Firmenzweck
Erwerb und Verwaltung von Beteiligungen an schweizerischen oder ausländischen Unternehmen aller Art; vollständige Zweckumschreibung gemäss Statuten.
Revisionsstelle
Aktive Revisionsstelle (1)
| Name | Ort | Seit | Bis | |
|---|---|---|---|---|
| Grant Thornton AG | Zürich | 23.12.2019 | ||
Weitere Firmennamen
Frühere und übersetzte Firmennamen
- Evalueserve Holdings SA
- Evalueserve Holdings Ltd
Zweigniederlassungen (0)
Besitzverhältnisse
Beteiligungen
Neueste SHAB-Meldungen: Evalueserve Holdings AG
Publikationsnummer: UP04-0000007542, Handelsregister-Amt Zürich
"Rubrik: Mitteilungen an Gesellschafter/nUnterrubrik: Einladung zur Generalversammlung/nPublikationsdatum: SHAB 06.01.2026/nÖffentlich einsehbar bis: 06.01.2027/nMeldungsnummer: UP04-0000007542/nPublizierende Stelle/nBaker McKenzie Switzerland AG, (Baker McKenzie Switzerland Ltd) (Baker McKenzie Switzerland SA),/nHolbeinstrasse 30.
8008 Zürich/nEinladung zur ausserordentlichen/nGeneralversammlung Evalueserve Holdings AG/nBetroffene Organisation:
/nEvalueserve Holdings AG/nCHE-229.673.474/nBahnhofstrasse 10/n6300 Zug/nAngaben zur Generalversammlung:/n27.01.2026, 17.00 Uhr, Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8008 Zürich,/nSchweiz/nEinladungstext/Traktanden:/nEinladung zur ausserordentlichen Generalversammlung der Evalueserve Holdings AG./nDen vollständigen Einladungstext, einschliesslich der Traktanden, der Anträge und der/nBegründungen des Verwaltungsrats, entnehmen Sie bitte dem angehängten PDF/nDokument. Die Teilnahme mittels elektronischer Mittel ist möglich./nZug, 5. Januar 2026/nEvalueserve Holdings AG/nArmin Meier/nPräsident des Verwaltungsrats/nTo the shareholders of:/nEvalueserve Holdings AG/nin Zug (CHE-229.673.474)/n5 January 2026/nInvitation to the extraordinary meeting of the shareholders/nDear shareholders,/nThe board of directors of Evalueserve Holdings AG, with registered office at Bahnhofstrasse/n10, 6300 Zug, (""Company"") invites you herewith to the extraordinary shareholders' meeting./nThe meeting takes place as follows:/n? Date: 27 January 2026/n? Time: 17:00 CET/n? Place: Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8008/nZurich.
Switzerland/n? Videoconference:
Shareholders may request the dial-ins from Navneet/nKhanna, Legal & Compliance and Company Secretary/n(Navneet.Khanna@evalueserve.com)./nPlease find below the following: (i) the agenda for the meeting and (ii) administrative/ninformation relevant for participating in the meeting./nI. AGENDA/nDistributions/nThe board of directors proposes to make cash distributions in an amount in USD/nequivalent to CHF 30,000,000.00, converted into CHF at the exchange rate applied by/nthe Swiss Federal Tax Administration on the date the shareholders' meeting resolves upon/nthe distributions (""Distributions"").
as follows:
/n2/n? first, CHF 25,800.00 of the retained earnings shown in the Company's annual/nfinancial statements as of 31 December 2024 shall be allocated to the Company's/ngeneral profit reserves (gesetzliche Gewinnreserve);
and then/n? a cash repayment from the legal capital contribution reserves as shown in the/nCompany's annual financial statements as of 31 December 2024, shall be made in/nan amount in USD equivalent to CHF 3,578,340.00, converted into CHF at the/nexchange rate applied by the Swiss Federal Tax Administration on the date of the/nshareholders' meeting resolves thereon, whereby payment shall be due on 31/nJanuary 2026;
and/n? an extraordinary cash dividend from the retained earnings shown in the Company's/nannual financial statements as of 31 December 2024, shall be made in the amount/nin USD equivalent to CHF 26,421,660.00, converted into CHF at the exchange rate/napplied by the Swiss Federal Tax Administration on the date the shareholders'/nmeeting resolves thereon, whereby payment shall be due on 31 January 2026./nThe Distributions shall be paid in USD, except in those cases where a certain shareholder/nrequests no later than 27 January 2026 payment in CHF, in which case the respective/namount to be distributed to such shareholder shall be converted into CHF at the exchange/nrate applied by the Company's bank as of the date of payment. Any currency conversion/ncost shall be borne by the respective shareholder requesting the payment in CHF and/ndeducted from the amount to be distributed to such shareholder./nII. ADMINISTRATIVE INFORMATION/n1. Authorized Shareholders/n Shareholders who are registered in the share ledger of the Company as of the date of the/n meeting are authorized to participate and to vote at the upcoming meeting./n2. Representation/n If you cannot participate at the meeting personally, you have the possibility to appoint a/n proxy in order to vote at the meeting by proxy. We kindly ask you to provide to your/n proxy a written power of attorney. The written power of attorney needs to be submitted/n to Navneet Khanna, Legal & Company Secretary (Navneet.Khanna@evalueserve.com)/n by no later than 20 January 2026. Please find attached hereto a template of a power of/n attorney you might wish to use in this regard. Please note that if there is no specific/n instruction given in your proxy, any proxy holder is deemed to be authorized to vote in/n accordance with the recommendations of the board of directors of the Company./n3. Indication of dividend payment currency/n If you wish to have your share of the Distributions be disbursed in CHF instead of USD,/n then please notify us by email to the attention of Navneet Khanna, Legal & Compliance/n and Company Secretary (Navneet.Khanna@evalueserve.com) with copy to Shahbaz/n 3/n Khan, Legal & Compliance (Shahbaz.Khan@evalueserve.com) no later than 27/n January 2026. Without such notice from you within said deadline, your share of the/n Distributions will be disbursed in USD./n4. Q&A/n Should you have any questions regarding this invitation or the preparation and use of a/n power of attorney, please refer to Navneet Khanna, Legal & Company Secretary/n (Navneet.Khanna@evalueserve.com)./n The auditor's reports of the Company confirming that the proposed Distributions (including the/n allocation of retained earnings in the amount of CHF 25,800.00 to the Company's general legal/n profit reserves (gesetzliche Gewinnreserve) comply with the Company's articles of association/n and statutory law can be requested from Navneet Khanna, Legal & Company Secretary/n (Navneet.Khanna@evalueserve.com)./n On behalf of the board of directors/n ________________________________/n Armin Meier/n Chairperson of the Board of Directors/n Attachments:/n ? Template power of attorney/n Copy to:/n Grant Thornton AG, in Zurich, as the statutory auditors/n POWER OF ATTORNEY/n The undersigned,/n ______________________________________________/n ______________________________________________/n (indicate name/company name and address)/n (""Principal"") grants hereby a power of attorney to/n _______________________________________________/n ______________________________________________/n (indicate name and business address)/n (the ""Attorneys""), upon each of them individually, to represent the Principal as shareholder at the upcoming/n extraordinary shareholders' meeting (even if held as a plenary meeting pursuant to article 701 CO) of Evalueserve/n Holdings AG, with registered office in Zug, (""Company"") and to vote and pass resolutions on the following/n agenda, whereby, unless expressly stated otherwise below.
the Principal's voting right is to be exercised in/n accordance with the motions of the board of directors:
/n Agenda Voting instructions/n Distributions/n Each Attorney may in his name and within his responsibility transfer to a substitute the execution of the powers/n granted to him by this power of attorney. The Attorneys are also allowed to represent various parties in the same/n matter (multiple representation)./n This power of attorney is governed by Swiss law. Any dispute in relation with this power of attorney is submitted/n to the exclusive jurisdiction of the competent court at the registered office of the Company in Zug, Switzerland./n _______________________________/n (indicate company name, if any)/n _______________________ ________________________________/n/n Date Name:/n _______________________ ________________________________/n/nDate Name:/n"
Publikationsnummer: HR02-1006500174, Handelsregister-Amt Zug, (170)
Evalueserve Holdings AG, in Zug, CHE-229.673.474, Aktiengesellschaft (SHAB Nr. 128 vom 07.07.2025, Publ. 1006376680).
Ausgeschiedene Personen und erloschene Unterschriften:
Mc Reynolds, Alexandra Morehouse, amerikanische Staatsangehörige, in Ross, CA (US), Mitglied des Verwaltungsrates, ohne Zeichnungsberechtigung.
Publikationsnummer: HR02-1006376680, Handelsregister-Amt Zug, (170)
Evalueserve Holdings AG, in Zug, CHE-229.673.474, Aktiengesellschaft (SHAB Nr. 130 vom 07.07.2023, Publ. 1005789842).
Statutenänderung:
24.06.2025. Kapitalband gemäss näherer Umschreibung in den Statuten. Die Generalversammlung hat mit Beschluss vom 24.06.2025 die Statutenbestimmung über die bedingte Kapitalerhöhung vom 13.12.2019 geändert. [bisher: Die Gründungsversammlung hat mit Beschluss vom 13.12.2019 eine bedingte Kapitalerhöhung gemäss näherer Umschreibung in den Statuten eingeführt.]
Trefferliste
Hier finden Sie eine Verlinkung des Managements auf eine Trefferliste zu Personen mit dem gleichen Namen, die im Handelsregister eingetragen sind.